TAMPA, FL / ACCESSWIRE / June 18, 2019 / Advanzeon Solutions, Inc. (OTC PINK: CHCR) (“Advanzeon” or the “Company”) announced today that on Friday, June 14, 2019, it filed its required SEC 10-Q for the first quarter of 2019. The significance of this filing is that, among other things, it brings the Company current in its financial filings, providing its shareholders with increased liquidity and the ability to more freely trade the Company’s stock. The filing also references an agreement signed by the Company with Concentra Health Services, Inc. (“Concentra”), which the Company believes will bring substantial value to the Company on a going-forward basis. To view the Company’s 10-Q, go to https://www.sec.gov/Archives/edgar/data/22872/000121390019010754/f10q0319_advanzeonsolutions.htm.
Clark A. Marcus, the Company’s CEO, stated, “This filing represents the result of a tremendous effort by the Company’s staff and, in particular, its accounting department, who worked diligently over the last few years to bring the Company’s financial filings up to date. Management believes that effort was well spent in that the Company has experienced a consistent expansion of its national footprint in the sleep apnea universe; has established a premier position in this space; and, has become, what we believe to be, the national leader in sleep apnea screening, testing and treatment – especially in the transportation industry. We are confident that the efforts to bring the Company’s financials current and place the Company in an expansion mode, as we have done, will bear fruits for our shareholders in the very near future.”
About Advanzeon Solutions, Inc.
Advanzeon Solutions, Inc. (OTC: CHCR) through its subsidiary, owns and operates the nation’s most complete sleep apnea program known as SleepMaster Solutions™ (the “Program”). Headquartered in Tampa, Florida, the Company’s Program is available in all fifty states and Washington D.C. The Program focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches that address both the specific needs of clients and changing healthcare industry demands. For more information, visit our website at www.advanzeon.com.
Safe Harbor Statement
This press release contains forward-looking statements that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans and objectives. In some cases, you may identify forward-looking statements by words such as “may,” “should,” “plan,” “intend,” “potential,” “continue,” “believe,” “expect,” “predict,” “anticipate” and “estimate,” the negative of these words or other comparable words. These statements are only predictions. One should not place undue reliance on these forward-looking statements. The forward-looking statements are qualified by their terms and/or important factors, many of which are outside the Company’s control, involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made. The forward-looking statements are based on the Company’s beliefs, assumptions and expectations of our future performance, taking into account information currently available to the Company. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to the Company. Neither the Company nor any other person assumes responsibility for the accuracy or completeness of these statements. The Company will update the information in this press release only to the extent required under applicable securities laws. If a change occurs, the Company’s business, financial condition, liquidity and results of operations may vary materially from those expressed in the aforementioned forward-looking statements.
Contact:
Philip Pulver
Communications Director
509-607-7229
ppulver@pvmsco.com
SOURCE: Advanzeon Solutions, Inc.
View source version on accesswire.com:
https://www.accesswire.com/549144/Advanzeon-Solutions-Inc-Brings-Financial-Filings-Current
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…